AKTX DCF Valuation - Akari Therapeutics PLC

Watchlist Manager

Watchlist

Price: 3.49 USD -5.68% Market Closed

Market Cap: $4.4m

	Akari Therapeutics PLC NASDAQ:AKTX	US
	Bidvest Group Ltd OTC:BDVSY	ZA
J	Jiangsu Expressway Co Ltd SWB:JE2	CN
	Adapthealth Corp NASDAQ:AHCO	US
	Cadiz Inc NASDAQ:CDZI	US
T	Transocean Ltd XBER:TOJ	CH
P	Priority Technology Holdings Inc F:60W	US
T	TCL Electronics Holdings Ltd XBER:TC2A	CN
S	Seven & i Holdings Co Ltd XMUN:S6M	JP
A	AMETEK Inc LSE:0HF7	US
E	Enbridge Inc SWB:EN3	CA
A	Automatic Data Processing Inc XETRA:ADP	US
S	Smoore International Holdings Ltd OTC:SMORF	CN
G	Goldman Sachs Group Inc SWB:GOS	US
A	Aramark SWB:0AK	US
S	Stellantis NV XBER:8TI	NL
O	OneSpan Inc XBER:VDY	US

AKTX's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.